{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T15:24:31Z","timestamp":1707233071772},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T00:00:00Z","timestamp":1316476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12325-011-0060-y","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T02:08:27Z","timestamp":1317780507000},"page":"866-878","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of cilostazol for intracranial arterial stenosis evaluated by digital subtraction angiography\/magnetic resonance angiography"],"prefix":"10.1007","volume":"28","author":[{"given":"Keiichi","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,20]]},"reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/0741-5214(84)90004-1","volume":"1","author":"P.G. Borozan","year":"1984","unstructured":"Borozan PG, Schuler JJ, LaRosa MP, Ware MS, Flanigan DP. The natural history of isolated carotid siphon stenosis. J Vasc Surg. 1984;1:744\u2013749.","journal-title":"J Vasc Surg"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/01.STR.13.6.825","volume":"13","author":"D.R. Craig","year":"1982","unstructured":"Craig DR, Meguro K, Watridge C, Robertson JT, Barnett HJ, Fox AJ. Intracranial internal carotid artery stenosis. Stroke. 1982;13:825\u2013828.","journal-title":"Stroke"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.STR.13.6.821","volume":"13","author":"D.J. Marzewski","year":"1982","unstructured":"Marzewski DJ, Furlan AJ, St Louis P, Little JR, Modic MT, Williams G. Intracranial internal carotid artery stenosis: longterm prognosis. Stroke. 1982;13:821\u2013824.","journal-title":"Stroke"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/01.STR.17.5.938","volume":"17","author":"N.A. Moufarrij","year":"1986","unstructured":"Moufarrij NA, Little JR, Furlan AJ, Leatherman JR, Williams GW. Basilar and distal vertebral artery stenosis: long-term follow up. Stroke. 1986;17:938\u2013942.","journal-title":"Stroke"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.STR.26.1.14","volume":"26","author":"R.L. Sacco","year":"1995","unstructured":"Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke. 1995;26:14\u201320.","journal-title":"Stroke"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1161\/hs1201.099652","volume":"32","author":"J.F. Arenillas","year":"2001","unstructured":"Arenillas JF, Molina CA, Montaner J, Abilleira S, Gonz\u00e1lez-S\u00e1nchez MA, Alvarez-Sab\u00edn J. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis. A long-term follow up transcranial doppler ultrasound study. Stroke. 2001;32:2898\u20132904.","journal-title":"Stroke"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/01.STR.17.6.1112","volume":"17","author":"J. Bogousslavsky","year":"1986","unstructured":"Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W, for the EC\/IC Bypass Study Group. Atherosclerotic disease of middle cerebral artery. Stroke. 1986;17:1112\u20131120.","journal-title":"Stroke"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1212\/WNL.45.8.1488","volume":"45","author":"M.I. Chimowitz","year":"1995","unstructured":"Chimowitz MI, Kokkinos J, Strong J, et al., for the Warfarin-Aspirin Symptomatic Intracranial Disease Study Group. The warfarin-aspirin symptomatic intracranial disease study. Neurology. 1995;45:1488\u20131493.","journal-title":"Neurology"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.STR.15.2.237","volume":"15","author":"R.N. Corston","year":"1984","unstructured":"Corston RN, Kendall BE, Marshall J. Prognosis in middle cerebral artery stenosis. Stroke. 1984;15:237\u2013241.","journal-title":"Stroke"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.410050208","volume":"5","author":"R.C. Hinton","year":"1979","unstructured":"Hinton RC, Mohr JP, Ackerman RH, Adair LB, Fisher CM. Symptomatic middle cerebral artery stenosis. Ann Neurol. 1979;5:152\u2013157.","journal-title":"Ann Neurol"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.105.578229","volume":"113","author":"S.E. Kasner","year":"2006","unstructured":"Kasner SE, Chimowitz MI, Lynn MJ, et al., Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:553\u2013563.","journal-title":"Circulation"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/01.STR.29.7.1389","volume":"29","author":"The WASID study group.","year":"1998","unstructured":"The WASID study group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke. 1998;29:1389\u20131392.","journal-title":"Stroke"},{"key":"60_CR13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/WNL.55.4.490","volume":"55","author":"V.N. Thijs","year":"2000","unstructured":"Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic thrapy. Neurology. 2000;55:490\u2013497.","journal-title":"Neurology"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1212\/01.wnl.0000175983.76110.59","volume":"65","author":"R. Kern","year":"2005","unstructured":"Kern R, Steinke W, Daffertshofer M, Prager R, Hennerici M. Stroke recurrence in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology. 2005;65:859\u2013864.","journal-title":"Neurology"},{"key":"60_CR15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa043033","volume":"352","author":"M.I. Chimowitz","year":"2005","unstructured":"Chimowitz MI, Lynn MJ, Howlett-Smith H, et al., Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305\u20131316.","journal-title":"N Engl J Med"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.STR.0000157667.06542.b7","volume":"36","author":"S.U. Kwon","year":"2005","unstructured":"Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke. 2005;36:782\u2013786.","journal-title":"Stroke"},{"key":"60_CR17","first-page":"643","volume":"21","author":"O.B. Samuels","year":"2000","unstructured":"Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standard method for measuring intracranial arterial stenosis. AJNR. 2000;21:643\u2013646.","journal-title":"AJNR"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1227\/01.NEU.0000204102.88016.33","volume":"58","author":"R.J. Komotar","year":"2006","unstructured":"Komotar RJ, Wilson DA, Mocco J, et al. Natural history of intracranial atherosclerosis: a critical review. Neurosurgery. 2006;58:595\u2013601.","journal-title":"Neurosurgery"},{"key":"60_CR19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.STR.29.2.433","volume":"29","author":"P. Akins","year":"1998","unstructured":"Akins P, Pilgram T, Cross DT 3rd, Moran CJ. Natural history of stenosis from intracranial athrosclerosis by serial angiography. Stroke. 1998;29:433\u2013438.","journal-title":"Stroke"},{"key":"60_CR20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/hs0202.102602","volume":"33","author":"K.S. Wong","year":"2002","unstructured":"Wong KS, Li H, Lam WW, Chan YL, Kay R. Progression of middle cerebral artery occlusive disease and relationship with further vascular events after stroke. Stroke. 2002;33:532\u2013536.","journal-title":"Stroke"},{"key":"60_CR21","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/STROKEAHA.108.546150","volume":"40","author":"B.M. Famakin","year":"2009","unstructured":"Famakin BM, Chimowitz MI, Lynn MJ, Stern BJ, George MG, for the WASID Trial Investigators. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke. 2009;40:1999\u20132003.","journal-title":"Stroke"},{"key":"60_CR22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.wnl.0000208404.94585.b2","volume":"66","author":"M. Mazighi","year":"2006","unstructured":"Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66:1187\u20131191.","journal-title":"Neurology"},{"key":"60_CR23","first-page":"563","volume":"37","author":"Y. Ikeda","year":"1987","unstructured":"Ikeda Y, Kikuchi M, Murakami H, et al. Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on palatelet function ex vivo. Randomized, double blind cross-over study. Arzneimittelforschung. 1987;37:563\u2013566.","journal-title":"Arzneimittelforschung"},{"key":"60_CR24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00005344-199212000-00009","volume":"20","author":"S. Takahashi","year":"1992","unstructured":"Takahashi S, Oida K, Fujiwara R, et al. Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of smooth muscle cell culture. J Cardiovasc Pharmacol. 1992;20:900\u2013906.","journal-title":"J Cardiovasc Pharmacol"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.0000117403.64398.53","volume":"109","author":"H.K. Shin","year":"2004","unstructured":"Shin HK, Kim YK, Kim KY, Lee JH, Hong KW. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lection-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation. 2004;109:1022\u20131028.","journal-title":"Circulation"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000138400","volume":"36","author":"T. Tanaka","year":"1988","unstructured":"Tanaka T, Ishikawa T, Hagiwara M, Onoda K, Itoh H, Hidaka H. Effect of cilostazol, a selective cAMP phosphodiesterase inhibitor, on the contraction of vascular smooth muscle. Pharmacology. 1988;36:313\u2013320.","journal-title":"Pharmacology"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000091534","volume":"21","author":"P.J. Laar Van","year":"2006","unstructured":"Van Laar PJ, van der Grond J, Mali WP, Hendrikse J. Magnetic resonance evaluation of the cerebral circulation in obstructive arterial disease. Cerebrovasc Dis. 2006;21:297\u2013306.","journal-title":"Cerebrovasc Dis"},{"key":"60_CR28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000121344","volume":"25","author":"J. Hendrikse","year":"2008","unstructured":"Hendrikse J, Klijn CJ, van Huffelen AC, Kappelle LJ, van der Grond J. Diagnosing cerebral collateral flow patterns: accuracy of non-invasive testing. Cerebrovasc Dis. 2008;25:430\u2013437.","journal-title":"Cerebrovasc Dis"},{"key":"60_CR29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000108509","volume":"4","author":"T. Uehara","year":"1994","unstructured":"Uehara T, Mori E, Tabuchi M, Ohsumi Y, Yamadori A. Detection of occlusive lesions in intracranial arteries by three-dimensional time-of-flight magnetic resonance angiography. Cerebrovasc Dis. 1994;4:365\u2013370.","journal-title":"Cerebrovasc Dis"},{"key":"60_CR30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1148\/radiology.185.3.1438743","volume":"185","author":"J.E. Heiserman","year":"1992","unstructured":"Heiserman JE, Drayer BP, Keller PJ, Fram EK. Intracranial vascular stenosis and occlusion: evaluation with three-dimensional time-of-flight MR angiography. Radiology. 1992;185:667\u2013673.","journal-title":"Radiology"},{"key":"60_CR31","first-page":"93","volume":"23","author":"T. Hirai","year":"2002","unstructured":"Hirai T, Korogi Y, Ono K, et al. Prospective evaluation of suspected stenoocclusive disease of intracranial artery: combined MR angiography compared with digital subtraction angiography. AJNR. 2002;23:93\u2013101.","journal-title":"AJNR"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1148\/radiology.193.1.8090890","volume":"193","author":"Y. Korogi","year":"1994","unstructured":"Korogi Y, Takahashi M, Mabuchi N, et al. Intracranial vascular stenosis and occlusion: diagnostic accuracy of three-dimensional, Fourier transform, time-of-flight MR angiography. Radiology. 1994;193:187\u2013193.","journal-title":"Radiology"},{"key":"60_CR33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/radiology.190.1.8259384","volume":"190","author":"K.U. Wentz","year":"1994","unstructured":"Wentz KU, R\u00f6ther J, Schwartz A, Mattle HP, Suchalla R, Edelman RR. Intracranial vertebrobasilar system: MR angiography. Radiology. 1994;190:105\u2013110.","journal-title":"Radiology"},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1124\/jpet.104.079780","volume":"313","author":"J.H. Lee","year":"2005","unstructured":"Lee JH, Oh GT, Park SY, et al. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-\u03b1 formation in low-density lipoprotein receptor-null mice fed high cholesterol. J Pharmacol Exp Ther. 2005;313:502\u2013509.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-011-0060-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-011-0060-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-011-0060-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:56:00Z","timestamp":1559447760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-011-0060-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,20]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s12325-011-0060-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,20]]}}}